Keep making the tablets!

08/05/2018
This article shows how valuable manufacturing production line downtime in the pharmaceutical industry can be reduced by ensuring predictive maintenance of tablet making machinery using Harting’s MICA industrial computing platform.

Introduction
Harting recently challenged postgraduate students from the Centre for Doctoral Training in Embedded Intelligence at Loughborough University to investigate practical application solutions where MICA – the company’s innovative open platform based ruggedised industrial edge computing device – could be applied to the benefit of manufacturing. Simple seamless integration within existing established production processes was the target, based on the concept of machine predictive maintenance.

The key objective was to achieve immediate productivity improvements and return on investment (RoI), thus satisfying the increasing trend for Integrated Industry 4.0 implementation on the factory floor. One such proposal was suggested for volume manufacturers in the pharmaceutical industry: in particular, those companies manufacturing tablets using automated presses and punch tools.

Data from these machines can be collected using passive UHF RFID “on metal” transponders which can be retrofitted to existing tablet press machines and mounted on the actual press-die/punch tools. The RFID read and write tags can record the pressing process, i.e. the number of operations performed by a particular press die, plus any other critical operating sensor-monitored conditions. The system can then review that data against expected normal end-of-life projected limits set for that die.

Such data can be managed and processed through Harting’s MICA edge computing device, which can then automatically alert the machine operator that maintenance needs to take place to replace a particular die-set before it creates a catastrophic tool failure condition and breakdown in the production line – which unfortunately is still quite a common occurrence.

Open system software
MICA is easy to use, with a touch-optimised interface for end users and administrators implemented entirely in HTML5 and JavaScript. It provides an open system software environment that allows developers from both the production and IT worlds to quickly implement and customise projects without any special tools. Applications are executed in their own Linux-based containers, which contain all the necessary libraries and drivers. This means that package dependencies and incompatibilities are eliminated. In addition, such containers run in individual “sandboxes” which isolate and secure different applications from one another with their own separate log-in and IP addresses. As a result, there should be no concerns over data security when MICA is allowed access to a higher-level production ERP network.

MICA is already offered with a number of containers such as Java, Python C/C++, OPC-UA, databases and web toolkits, all available on free download via the HARTING web site. As a result, users should be able to download links to the operating software system compatible with an existing machine, enabling full 2-way communication with the MICA device. Relaying such manufacturing information, which can comprise many gigabytes of data in the course of a day, directly to the ERP would normally overwhelm both the network and the ERP. With the MICA, this data stream is buffered directly onto the machine and can be reduced to just essential business-critical data using proven tools from the IT world.

The resultant improvements in productivity include:

– Less downtime reduces the amount of money lost during unforeseen maintenance of damaged punch tools.
– Individual punch identification will help in removing a specific punch, once it has reached its pre-set operational frequency working limit.
– A digital log of each punch and the number of tablets that it has produced is recorded. This provides vital information for GMP (Good Manufacturing Practice) regulators such as the MHRA (Medicines & Healthcare products Regulatory Agency) or the FDA (Food & Drug Administration).

A further benefit is that MICA is very compact, with DIN rail mounting fixing options that allow it to be easily accommodated inside a machine’s main control cabinet.

@HARTING #PAuto #Pharma @CDT_EI

Connecting, communicating and creating in Netherlands.

14/03/2018

The country of the Netherlands is where the Rhine enters the sea. It is a country which has physically built itself out of the inhospitable North Sea. Often called Holland – which is the name of one (actually two) of its provinces – it even more confusingly for the English speaking world inhabited by the Dutch speaking Dutch. If you really want to know more about Holl.. er sorry, The Netherlands watch the video at the bottom of this piece.

Although not officially the capital of The Netherlands, Amsterdam is, The Hague is the seat of Government and official residence of the King. It was selected by the Emerson User Group as the venue for their European, Middle East & African assembly, refereed to as #EMrex on twitter. These assemblies – can we say celebrations? – occur every two years. The last was held in Brussels, the capital of the neighbouring Kingdom of the Belgians and of the European Union. An sccount of happenings there are in our postin “All change at Brussel Centraal.” (18/4/2016)

Lots of pictures from the event!

The size of this event was in marked contrast to the Brussels meet which was overshadowed by the terrible terrorist attacks in that city only three weeks earlier which presented transport difficulties. This time there were over one thousand six hundred delegates filling the huge hall of the Hague Convention Centre.

Another difference referred to in many of the discussions both formal and informal were the two great uncertainties effecting all businesses and industries – the possibility of a trade war with the USA under its current administration and nearer home the aftermath of the BREXIT decision – the exit of the British from the largest economic bloc on the planet. Many developments have been put on the long finger pending clarification on these issues.

Mary Peterson welcomes delegates

Why are we here?
This event continued in the vein of previous meetings. The emphasis continuing to move to perhaps a more philosophical and certainly a more holistic view of how the automation sector can help industry. This was made clear in the introductory welcome by Novartis’s Mary Peterson, Chair of the User Group, when she posed the question, “Why are we here?”

“This is a conference for users by users.” she said. It is a place to discuss users’ practical experiences; continuing our profissional development; learning best practice and proven solutions and technology roadmaps. But above all it presented an opportunity to connect with industry leaders, users and of course Emerson experts.

For other or more detailed information on happenings and/or offerings revealed at this event.
News Releases

and on Twitter #EmrEx

The emphasis is on the totality of services and packages not on individual boxes. Emerson’s European President Roel Van Doren was next to address the assembly. We should know our plant but be unafraid to use expertese and knowledge to keep it fit for purpose. Monitor the plant constantly, analyse what is required and then act. This means seeing how the latest advances might improve production. This means harnessing the “new technologies.” In passing he drew our attention that Emerson had been recognised earlier this year as ‘Industrial IoT Company of the Year’ by IoT Breakthrough.

The path is digital
A very striking presentation was given by Dirk Reineld, Senior VP Indirect Procurement with BASF. He brought us to the top of Rome’s Via de Conciliazione on 19th April 2005. We saw the huge crowd looking towards the centre balcony as the election of a new pope was announced. He then moved forward to the 13th March in 2013, the same place but what a difference in such a short time. This time it seemed that everybody had a mobile phone held to take photographs of the announcement of the election of Francis. All we could see was a sea of little screens. He used this to emphasize a point “We are underestimating what is happening & its speed.” This is not helped by a natural conservatism among plant engineers. Change is happening and we either embrace it or get left behind. It is becoming more and more clear that in front of us “the path is digital!” He presented some useful examples of digitalisation and collaboration at BASF.

PRESENTATIONS

Registered delegates have access to slides from the main presentation programme. These slides are available for download via the Emerson Exchange 365 community (EE365).

Emerson Exchange 365 is separate from the Emerson Exchange website that presenters & delegates used before Exchange in The Hague. So, to verify your attendance at this year’s conference, you must provide the email you used to register for Exchange in The Hague. If you are not already a member of EE365 you will be required to join.

To access the presentations, visit The Hague 2018 and follow the prompts. The first prompt will ask you to join or sign in.

Something in this particular EmrEx emphasised how things are moving and those unprepared for the change. Among some of the press people and others there was disappointment expressed that there was not a printed programme as in previous years. This correspondent is used to going away into a corner and combing through the printed agenda and selecting the most relevant sessions to attend. This was all available on line through the “Emerson Exchange Web App.” This was heralded as a “a great preshow planning tool.” All we had to do was enter a link into our our web-browser on our phones and away you went. Yes this is the way to go certainly and although I am inclined to be adventurous in using social media etc I and some (if not many) others found this a step too far to early. It was not clear that a printed version of the programme would not be available and the first hour of a conference is not the best time to make oneself au fait with a new app.

Having said that while many of the journos took notes using pencil and paper they were not adverse to taking photos of the presentation slades so they could not be said to qualify as complete luddites!

Terrific progress but…

Rewards of efficiency
This event was being held at the same time as CERAWeek 2018 in which Emerson was an important participant. Some Emerson executives thus made the trans Atlantic journey to make presentations. One of those was Mike Train, Emerson’s Executive President who delivered his talk with no apparent ill effects. In effect he was asking a question. “Just how effective is progress?” Yes, we HAVE made phenomenal progress in the last 30 years. “Modern automation has made plants more efficient, reliable and safer, but, the ‘Efficiency Era’ is reaching diminishing returns….Productivity seems to be stagnation while the workforce is stretched.”

He postulated five essential competancies for digital transformation.

  1. Automated workflows: Eliminate repetitive tasks and streamline standard operations.
  2. Decision support: Leverage analytics and embedded exportise.
  3. Mobility: Secure on-demand access to information and expertese.
  4. Change management: Accelerate the adoption of operational best practices.
  5. Workforce upskilling: Enable workers to acquire knowledge and experience faster.

Making the future!

Making the future
The next speaker was Roberta Pacciani, C&P Manager Integrated Gas and Upstream Technology with Shell. She is also President of the Women’s Network at Shell Netherlands. She spoke on leveraging the best available talent to solve future challenges. I suppose that we would have classified this as a feminist talk but of course it isn’t. As the presenter said it is not so much a feminist issue as a people issue. “Closing the gender gap in engineering and technology makes the future.”  This was a useful presentation (and in this correspondent’s experience unusual) and hopefully will be helpful in changing perceptions and preconceptions in STEM and our own particular sector.

As partof EmrEX there is an exhibition, demonstration area. Delegates may see innovative technologies applied to their plant environment. They meet with experts about topics such as getting their assets IIoT ready or how to use a Digital Twin to increase performance and explore options to prepare their plant for the future. As a guide – printed as well as on-line – the produced a Metro-like guide.
Using this we could embark on a journey through products, services and solutions where Emerson together with their partners could help solve operational and project challenges.

One of the most popular exhibits was the digital workforce experience. Here we visited a plant and were transported magically to former times to see just how different plant management is now and particularly with the help of wireless and digitisation.

It happened!

One of the good things about this sort of event is the opportunity to meet friends for the first time though social media. Sometimes one does not know they are attending unless the tweet something. Thus I realised that an Emerson engineer was present and so I went looking for him in the expos area. This it was that Aaron Crews from Austin (TX US) and I met for the first time after knowing each other through twitter & facebook for a frightening ten years. Another of these virtual friends, Jim Cahill, says, “It hasn’t happened without a picture!” So here is that picture.

The following morning there were a series of automation forum dedicated to various sectors. The Life-Sciences Forum was one which was very well attended.  Ireland is of course a leader in this sector and we hope to have a specific item on this in the near future. Emerson have invested heavily in the national support services as we reported recently.

Each evening there were social events which provided further opportunities for networking. One of these was a visit to the iconic Louwman Transport Museum where reside possibly the largest collections of road vehicles from sedan chairs through the earliest motor cars up to the sleekest modern examples. These are all contained in a beautiful building. The display was very effectively presented and one didn’t have to be a petrol-head – and believe me there were some among the attendance – to appreciate it.

It is impossible to fully report an event like this in detail. One can follow it on twitter as it happens of course. And there will be copies of many of the presentations and videos of some of the sessions on the website.

The Emerson User Group Exchange – Americas will continue “spurring innovation” in San Antonio (TX USA) from 1st to 5th October 2018. It looks exciting too.

We promised at the top of this blog an exposé of the country often called Holland in English –


So now you know!

@EMR_Automation #Emrex #Pauto

Permission to change and develop in the Life Sciences!

20/06/2017
• Enjoy a unique environment to meet and gain input from all stake holders on industry direction, challenges and solutions.
• Shape your strategy on the way solutions should be developed and applied in your facility
• Understand how partnering can take you further, faster and with reduced risk
• Experience hands on demonstrations of automation equipment and packages.

The invitation was interesting, and challenging. “Future.Now – Developing the Life Sciences Landscape Together” was an arresting title. It was a co-operative event between National Institute for Bioprocessing Research and Training (NIBRT) and Emerson. We were invited to “Boost your knowledge, gain from the experience of others and increase your professional network at NIBRT state of the art facility in Dublin!”

Mike Train, Executive President with Emerson explains their focus under the attentive eye of European President Roel Van Doren.

This correspondent was aware of the NIBRT facility but had very little idea of what it was real function or its relevance to Irish industry. This was an opportunity find out. Further looking through the programme two things became apparent. One was the calibre of personnel speaking from the Emerson organisation and then the application rather than product orientation of the various sessions.

It proved to be a very interesting two days.

Day 1: Working together towards a common future.
Presentations from NIBRT, Industrial Development Authority (IDA), GSK, Alexion, Zeton, Novo Nordisk and Emerson Automation Solutions.

Pharma v Biopharma

After a short welcome fro Emerson Europe President, Roel Van Doren, the CEO of NIBRT, Dominic Carolan, outlined the foundation and raison d’etre of the organisation. It is a training and research in the area of bioprocessing. It is located in a new, world class facility in Dublin (IRL). As medical science advances “simple” chemistry, while still essential, is not fully capable of solving all health issues – Pharma versus Biopharma. Bioprocessing is a specific process that uses complete living cells or their components (e.g., bacteria, enzymes, chloroplasts) to obtain desired products.

Thus this facility exists to support the growth and development of all aspects of the biopharmaceutical industry in Ireland. It is purpose built to closely replicate a modern bioprocessing plant with state of the art equipment.

Making Ireland ready – a good news story.
Dr Chantelle Keirnan, Scientific Advisor with the Industrial Development Authority (IDA), described the far-seeing intuitive initiative to look at bioprocessing “before it was profitable or popular!” This state body is responsible for the attraction and development of foreign investment in Ireland and had been extraordinarily successful in attracting nine of the top ten pharma companies to set up manufacturing processing plants in Ireland. They considered at the turn of the century that bioprocessing was the way that life science was going and took steps to ensure that Ireland was ready. One of those steps was the provision of Government funding of NIBRT.

Togged out for the tour

Many of the delegates – in excess of one hundred attended some from other countries – donned white coats and took the opportunity to tour the impressive facility during the event. It includes a purpose-built, multi-functional building which replicates the most modern industrial bioprocessing facility. Some idea of this facility may be gleaned from their website here.

This is a good news story. How often are decisions of state organisations regarded, not entirely without justification, with a jaundiced eye? Those that are good are “oft interréd with their bones!” The vision that saw this development in industry and the individuals who having caught the ball ran with it and brought it so successfully to fruition is worthy of equal attention and praise.

The rest of the day was an examination of the industry, processes and looking into the future. Mike Train, Executive President of Emerson spoke on the changes that are influencing industry and his company’s focus. We are facing “an evolution not a revolution” he stated, a point emphasised by other speakers throughout the day. He also stressed the importance for giving permission to change. (See full list of speakers at below.)

Pictures from the event!

We then had a series of speakers from the industry, people who get their hands dirty so to speak in actual processing speaking of their experiences and challenges. Speakers from GSK and Novo Nordisk explored areas like partnership, legacy issues, building on or expanding existing plants, saving energy, wireless. There was some discussion on the cloud and its advantages and just how vulnerable it might be to security breaches.

The discussion on handling all this data and identifying and retrieving those pieces of data which are really useful to the process brought to mind the prophetic words of the American media theorist, Neil Postman years ago, “…a central thesis of computer technology – that the principal difficulty we have in solving problems stems from insufficient data – will go unexamined. Until, years from now, when it will be noticed that the massive collection and speed of light retrieval of data have been of great value to large scale organisations but have solved very little of importance to most people and have created at least as many problems for them as they have solved…” (Neil Postman: “Amusing ourselves to death:” 1985)

Peter Zornio, Chief Technology Officer with Emerson gave their philosophy in meeting the demands of “Life Science Visions.” He lauded the various discussion groups such as the Biopharma Operations Group in helping how to keep up to date with technology and fostering new ideas.

We are on a digitizing journey. Moving from manual and paper to digital recording and control.

Day 2: “New Technology, New Processes, New solutions!”
Presentations from BioPharmaChem, GSK, Infinity Automation and Emerson.

The day started with a presentation on modular flexible manufacturing – introducing the PK Controller and a little later in the day there was an exposition on DeltaV Discovery/DeltaV 14 in maintaining data and transferning and easing technology transfer through the life cycle of drug development.

In his second presentation Peter Zornio gave the business case behing IIoT. IoT is usually referring to domestic, building environment and other civil applications. But it is also useful in the industrial environment where it is referred to as IIoT. Initially it was a link up at the instrument and control area but of late it is spreading to the portfolio of sensors. Their emphasis is on “the first mile!” (This is a backward reference to the perennial problem in many, especially rural, areas of “the last mile” – the internet connection directly into the home! – a heart felt sigh from your correspondent!)

The Real Challenges!

Ian Allen of Infinity Automation spoke on challenges to the life science automation world. “Don’t go backward to go forward” he said. We must use things like data integrity, cyber security, Microsoft dependencies and Industrie 4.0 as “gifts to leverage the opportunity and change!” The real challenge is not so much the technology but our use of it. We were coming back to “permission for change!”

We might perhaps use the words of the Bard of Avon, “The fault, dear Brutus, is not in our stars. But in ourselves….”  The “gifts” are there. The Technology is there or on the way.

Let’s own these gifts and make them our own.

 

Pic: Travis Hesketh


The Speakers:

Day 1
Dominic Carolan
CEO – NIBRT
Dominic Carolan was appointed CEO of NIBRT in April 2015. Mr. Carolan previously held senior roles in Mallinckrodt (Dublin), Genzyme (Waterford), also Genzyme (Corporate) where he was Senior Vice President of Manufacturing, and in Sanofi, where he headed their global network of Sterile Injectable Lyophilisation sites. He has successfully lead the startup of two significant Pharma & BioPharma facilities in Ireland and has a proven track record in operations leadership and in attracting and developing the talent required to deliver long term success. A graduate of UCD in Chemical Engineering, Mr. Carolan was Chairman of BioPharmaChemical Ireland from 2008-2010.
Dr Chantelle Kiernan
Scientific Advisor – IDA

Dr. Chantelle Kiernan joined IDA in September of 2009 and is responsible for attracting research related foreign direct investment for Ireland. Chantelle has responsibility for the Multinational research portfolio – spanning Pharmaceutical, Biotechnology, Medical Device, Engineering Food services industries. Chantelle has spent her career equally dispersed between academia and industry. She holds a PhD in Immunology from Trinity College Dublin in the area of immunomodulation and continued her academic career with a Post-Doctoral fellowship in Harvard University, Boston. Chantelle is currently undertaking an MSc in International Business law. She has spent almost fifteen years in industry. In her current role as Scientific Advisor for the IDA, she has been integrally involved in attracting and securing large scale R&D foreign direct investments for Ireland.

Mike Train
Executive President – Emerson Automation Solutions
Michael H. Train leads the Automation Solutions business of Emerson, which posted sales of $10.2 billion in fiscal 2015. Train began his career with Emerson in 1991 as an international planner, then took on additional responsibilities in a number of executive posts that included serving as President of Emerson Japan and Korea, VP of Corporate Planning, President of Emerson Process Management Asia Pacific, and President of Emerson’s Rosemount business. He was most recently President of Global Sales for Emerson Process Management, responsible for sales, service, support, and customer satisfaction for all products and services across five world-area organizations. In that role he was also part of the leadership team that drove strategic initiatives and investments for the entire business group. Train earned a bachelor’s degree in electrical engineering from General Motors Institute and an MBA from the Johnson Graduate School of Management at Cornell University. He currently serves on the management school’s advisory council and was a 2008 Eisenhower Fellowship recipient.
Dave Tudor
Vice President, Head of GMS Strategy – GSK
Dave joined GSK in 1992 at Worthing as a PhD Chemist from Glasgow University. He has over 20 years’ experience with the company carrying out a number of Technical, Compliance and Manufacturing leadership roles. In 1997 he moved to Irvine to take up a lead chemist role before coming Quality Control Manager in 1998. He joined the site leadership team in 2001 to run Technical Development before moving to manufacturing as Actives Production Director in 2005. During this time he completed a Masters degree in Manufacturing Leadership at Cambridge University. In 2007 he moved to GSK House to work on a central network re-structuring project before becoming Site Director at Montrose in October 2008. At Montrose, he led the transformation of the site to manufacture over 12 products for GSK including a major investment programme. In 2011 he was appointed VP Primary Supply Chain with responsibility for global Active Pharmaceutical Ingredients (API) manufacture and supply, a network of GMS sites across the world including facilities in Asia and Europe. In 2017 he was appointed VP Head of GMS Strategy with responsibility for manufacturing strategy, deployment of strategic programmes, performance management and advocacy. He plays an active role with a number of Governments and is currently co-chair of the Life Sciences Scotland Industry Leadership Group. Dave is also a member of UK Chemicals Industry Association Council and Board. Dave is married with 4 children and lives in Troon, Ayrshire. He enjoys all sports, particularly football, is a keen reader of Scottish history and does cooking to relax.
Peter Zornio
Chief Strategic Officer – Emerson Automation Solutions
As Chief Strategic Officer for Emerson Automation Solutions, Peter has responsibility for overall coordination of technology programs, product and portfolio direction, and industry standards across the Automation Solutions group. He has direct responsibility for the product definition and development organizations for control systems and software products. He has been at Emerson for 10 years. Prior to Emerson, he spent over 20 years at Honeywell in a variety of technology and marking roles, most recently as overall product management leader. Peter holds a degree in Chemical Engineering from the University of New Hampshire.
Herman Bottenberg
Marketing Director,, Zeton

PDEng. Ir. Herman Bottenberg is a chemical engineer with 15+ years of industrial experience, along with two years of Post academic work on Plant Design. He worked for 17 years at Zeton B.V. in The Netherlands, with five years of experience in project engineering and project management. The last 12 years he has been active in business development, sales and marketing. Since 2016 Herman is also responsible for the Marketing and Sales group at Zeton B.V. Herman has specialised in transformation of processes from batch to continuous, process intensification and modular processing plants for pharma and chemical industry.

Day 2
 Matt Moran
Director – BioPharmaChem Ireland
Matthew Moran is Director of BioPharmaChem Ireland. He graduated in Chemistry at Trinity College Dublin in 1980 and in Chemical Engineering at University College Dublin in 1981; he holds an MBA also from University College Dublin (Smurfit School of Business). He worked for over ten years in the pharmaceutical industry where he held a number of management positions both in active ingredient and dosage form manufacture. He is a member the European Chemical Industry Council (CEFIC). Matthew Moran is a Board member of the Active Pharmaceuticals Ingredients (API) Committee of CEFIC (CEFIC/APIC) and The European Association for Bioindustries (Europabio) BioPharmaChem Ireland represents the interests of the biopharmachem sector in Ireland. CEFIC/APIC represents the European API Industry. Europabio represents the European Biotech Sector.
Ian Allan
Automation Consultant – Infinity Automation
Currently the Managing Director of Infinity Automation, a relatively new company carrying out Automation & MES Consultancy, Strategic Planning and Major Program/Project Health checks, with blue chip Global Life Science companies and Strategic vendors that support that Industry. Formerly Ian was the Global Head of Automation & MES with Novartis, where he was responsible for the Manufacturing Automation Strategy and MES Program within Technical Operations in the Vaccines division.  Prior to that he worked for GSK as Global Automation Director responsible for Automation, Process Control and MES across 73 sites worldwide. There he led a team that developed a library of Emerson DeltaV modules to be deployed in multiple Bulk API sites across the world, as well as developing a blueprint for MES integration and Network delivery of Electronic Batch Records. Prior to that he held several roles in GSK within the Engineering and Automation departments. Ian started his career with IBM as a junior engineer when computers were a little bigger than they are today and holds a BSc in Electrical & Control Engineering from Strathclyde University. He is currently facilitating GSK’s Global Automation Steering Team and is leading the Digital Factory Automation workstream for a new Hybrid Manufacturing platform with the first instance being delivered in GSK Singapore Jurong site.
Colin Chapman
Director of Manufacturing IT – GSK
Colin Chapman is a Chemical Engineer with nearly 20 years experience in Life Sciences with GSK. Colin’s career has spanned across process engineering & automation, operations and new product introduction in both commercial manufacturing and clinical supply chains. In his current role as Director of Manufacturing IT Colin has successfully led the introduction of Manufacturing Operations Management across the clinical supply chain driving business process re-engineering and global workflow automation using technologies such as Syncade. GSK’s continuing program focuses on three value drivers, Compliance, Business Intelligence and Productivity.
Klaus Erni
Product Manager & Namur 148 Board Member – Emerson Automation Solutions
Klaus started his Emerson career in 2003 in Germany, where he was working as a Technical Manager for Key Accounts before he transferred to Austin, TX to become the DeltaV Hardware Product Marketing Manager. In 2015, he went back to Europe and took over another Global Role, being now the Technical Consultant to some major Strategic Accounts. While in Germany with Emerson, he was responsible for the technical aspects of the DeltaV Systems during the Sales and Implementation Phase, as well utilizing the latest Hardware and Software features while upgrading and expanding Systems on Key Customer sites. Prior to Emerson, Klaus was with the Hoechst AG, he did several Engineering projects with various PLC and DCS and SIS Systems and was as well a RS3 System User.
Danny Vandeput
Director Pervasive Sensing Strategies – Emerson Automation Solutions
The (Industrial) Internet of Things (IIoT) is revolutionizing the way we live but it also provides many new challenges to the industry. This can create confusion, uncertainty – combined with fuzzy statements – and different opinions. My great passion is to bring clarity in the Industrial Internet of Things and what benefits it can bring for you. I help industries to find the right perception of IIoT, how sensors can maximize profit, reduce downtime and bring the ROI into the IoT. Being already 23 years with Emerson I have assisted many types of industries on their way to Top Quartile Performance. This includes amongst other trainings, workshops, audits and implementing solutions.
#PAuto @EMR_Automation @NIBRT_ #IIoT @HHC_Lewis

Interesting facts emerge from financial report.

15/05/2017
E+H reports sales flat, but sees growth in Ireland, reports Processingtalk.info‘s  Nick Denbow from Basel.

This year, Endress+Hauser expanded the presentation of their annual financial results, inviting journalists from not only Germany and Switzerland, but including others from Belgium, the Netherlands and Great Britain. In all 70+ attendees heard Klaus Endress and Matthias Altendorf say that the consolidated Group sales fell slightly between 2015 and 2016, by 0.2%, achieving Euro2.1Bn. This fall was actually only because of currency fluctuations. “Currencies created a headwind for us last year,” said Altendorf. Working from the value of sales in local currencies, sales in total actually increased by 2.1%. Whilst the Group is family owned, their annual report is published and audited to the standards expected of any other international business.

CEO Matthias Altendorf emphasised that “When compared to overall industry growth, we held our own”. E+H performed well in Europe, but sales in America declined. Africa and the Middle East experienced solid growth, but in the Asia-Pacific region business stagnated.

Within Europe, the best performances for E+H came from Ireland, Italy and Finland. The best performing sectors in all countries were food & beverage, life sciences, and water & waste water. Overall business declined in oil & gas, chemicals and primary industries like metals. The power and energy industry sectors showed good performance outside Germany, where E+H also felt the effect of weak German exports and some internal restructuring. The oil & gas decline badly affected sales in USA, UK and Norway, although the UK sales centre gave a good performance by aligning efforts with other active market sectors.

Investment continues.

Production

E+H plans for investment and growth continue for the current year. Earlier in the week a new factory extension was opened in Reinach, where flow products are manufactured. (see Read-out Signpost – “Flowmeter output growth requires new facilities” – 5 May 2017).  The journalists were given a tour of the manufacturing facility in Maulberg (D), where a new extension to the production area is in operation, and a new NMi level measurement system calibration facility for radar based systems has just been completed. This is certified suitable for calibration of the Micropilot NMR81 radar system, working at 80GHz, which achieves a +/-0.5mm accuracy over a 30m range, for use in oil storage tanks and oil terminals. There are plans now to extend this calibration facility to allow such calibration out to 40metres, as well as to extend the factory yet further: 1912 people work at E+H Maulburg, and 5200 people in the Basel region, out of the total E+H staff of 13,000.

Analytical measurements
The biggest growth area in E+H is actually in the analytical instruments that use Raman spectroscopy to analyse liquid and gas streams on-line. The major industries now applying this technique are within the life sciences sector, where immediate analysis of input and both gaseous and liquid effluent streams enables much closer control of biochemical and fermentation processes. Indeed the 2017 issue of the E+H corporate magazine “Changes” features a major focus on new applications in the Life Sciences industries.

Other new analytical techniques are developed for monitoring water treatment processing, for example in the new Swiss plants which by law have to have a fourth stage of purification, to remove hormones, phosphorus and other drug residues. The strength of E+H here derives from their strategic decision a few years ago to invest in the process analytical area, particularly in the field of spectroscopy, acquiring Kaiser Optical, Analytik Jena and SpectraSensors. “Our analytics strategy has been validated by the market,” said Matthias Altendorf.

Bundling IIoT activities

Digitization

The acquisition of German SensAction AG in early 2017 also ties in with Strategy 2020+ which was rolled out last year. The company, headquartered in Coburg (D), manufactures innovative systems for measuring concentrations in liquids. Endress+Hauser is tackling the challenges of digitalization by bundling a number of activities. A new subsidiary in Freiburg in Breisgau,(D), is working exclusively on products, solutions and services related to the Industrial Internet of Things (IIoT).

The significance of digitalization can also be seen in the growing number of patent registrations. There were 273 first filings in 2016. The intellectual property rights portfolio thus boasts more than 7,000 active patents. R&D spending rose to 7.8 percent of sales. Endress+Hauser introduced 64 new products to the market. “We are investing in innovation for our customers,” underlined the CEO.

Trends in automation.
The focus for E+H sales and their customer base is broadly on automation engineers, so it was interesting to hear Matthias Altendorf comment that the statistics for industrial output show that the Britain has now dropped out of the top 10 countries in terms of automation business activity, whereas they had held a prominent position there some years ago.

The other aspect of interest was that there are distinct differences between countries, in terms of the sex of the engineers involved in the major projects served by E+H. In Germany they are mostly male, whereas the majority of engineers in Turkey are female. In South Korea and India there are high percentages of female engineers (and engineering journalists). Also, by industry, it is noticeable that in the biochemical and life science sectors the engineers are predominantly female.

 @Endress_Hauser #PAuto #IoT

Continuous compliance with PLM.

27/07/2016
Adam Bannaghan, technical director of Design Rule, discusses the growing role of PLM in managing quality and compliance.

The advantages of product lifecycle management (PLM) software are widely understood; improved product quality, lower development costs, valuable design data and a significant reduction in waste. However, one benefit that does not get as much attention is PLM’s support of regulatory compliance.

Compliance-PLMNobody would dispute the necessity of regulatory compliance, but in the product development realm it certainly isn’t the most interesting topic. Regardless of its lack of glamour, failure to comply with industry regulations can render the more exciting advantages of PLM redundant.

From a product designer’s perspective, compliance through PLM delivers notable strategic advantages. Achieving compliance in the initial design stage can save time and reduce engineering changes in the long run. What is more, this design-for-compliance approach sets the bar for quality product development, creating a unified standard to which the entire workforce can adhere. What is more, the support of a PLM platform significantly simplifies the compliance process, especially for businesses operating in sectors with fast-changing or complicated regulations.

For example, AS/EN 9100, is a series of quality management guidelines for the aerospace sector, which are globally recognised, but set to change later this year. December 2016 is the target date for companies to achieve these new standards – a fast transition for those managing compliance without the help of dedicated software.

Similarly, the defence industry has its own standards to follow. ITAR (International Traffic in Arms Regulations) and EAR (Export Administration Regulations) are notoriously strict exporting standards, delivering both civil and criminal penalties to companies that fail to comply.

“Fines for ITAR violations in recent years have ranged from several hundred thousand to $100 million,” explained Kay Georgi, an import/export compliance attorney and partner at law firm Arent Fox LLP in Washington. “Wilful violations can be penalised by criminal fines, debarment, both of the export and government contracting varieties, and jail time for individuals.”

PLM across sectors
The strict nature of all these regulations is not limited to aerospace and defence however. Electrical, food and beverage, pharmaceutical and consumer goods are also subject to different, but equally stern, compliance rules.

Despite varying requirements across industries, there are a number of PLM options that support compliance on an industry-specific basis. Dassault Systèmes ENOVIA platform, for example, allows businesses to input compliance definition directly into the program. This ensures that, depending on the industry, the product is able to meet the necessary standards. As an intelligent PLM platform, ENOVIA delivers full traceability of the product development process, from conception right through to manufacturing.

For those in charge of managing compliance, access to this data is incredibly valuable, for both auditing and providing evidence to regulatory panels. By acquiring industry-specific modules, businesses can rest assured that their compliance is being managed appropriately for their sector – avoiding nasty surprises or unsuccessful compliance.

For some industry sectors, failure to comply can cause momentous damage, beyond the obvious financial difficulties and time-to-market delays you might expect. For sensitive markets, like pharmaceutical or food and beverage, regulatory failure can wreak havoc on a brand’s reputation. What’s more, if the uncompliant product is subject to a recall, or the company is issued with a newsworthy penalty charge, the reputational damage can be irreparable.

PLM software is widely regarded as an effective tool to simplify product design. However, by providing a single source of truth for the entire development process, the potential of PLM surpasses this basic function. Using PLM for compliance equips manufacturers with complete data traceability, from the initial stages of design, right through to product launch. What’s more, industry-specific applications are dramatically simplifying the entire compliance process by guaranteeing businesses can meet particular regulations from the very outset.

Meeting regulatory standards is an undisputed obligation for product designers. However, as the strategic and product quality benefits of design-for-compliance become more apparent, it is likely that complying through PLM will become standard practice in the near future.

#PLM @designruleltd #PAuto #Pharma #Food @StoneJunctionPR

Compliance – more than just red tape.

03/07/2016

A growing customer demand for regulatory compliance combined with increased competition amongst manufacturers has made SCADA software a minimum requirement for the pharmaceutical industry. Here, Lee Sullivan, Regional Manager at COPA-DATA UK discusses why today, more than ever before, regulatory compliance is crucial for the pharmaceutical industry.

copabatchstdFDA statistics are forcing the industry to identify and implement improvements to its manufacturing processes. In its latest reports (published in Automation World), the FDA identified a significant increase in the number of drug shortages reported globally. With 65% of these drug shortage instances directly caused by issues in product quality, it’s clear that if more pharma manufacturers aimed to meet the criteria outlined in FDA and other industry standards, drug shortages and quality issues would certainly become less frequent.

The compulsion to become compliant obviously differs from company to company and standard to standard but one thing is certain: development starts with batch software. The range and capabilities of batch software vary immensely, but there are three factors to consider before making a choice: flexibility, connectivity and ergonomics.

Flexibility
To assist the complex processes of pharmaceutical manufacturing, batch software needs to be flexible. The software should manage traceability of raw materials through to the finished product and communicate fluently with other equipment in the facility. To ensure it provides a consistent procedure and terminology for batch production, the software should also be in line with the ISA-88 standard.

To meet increasing demand for personalised medication, manufacturers are seeking out batch software that is capable of creating flexible recipes, which are consistently repeatable. Traditional batch control creates one sequence of each process-specific recipe. While this model may be ideal for high volume manufacturing where the recipe does not change, today’s pharmaceutical production requires more flexibility.

To remain competitive, manufacturers need to provide compliance in a quick and cost-effective manner. Modern batch control software ensures flexibility by separating the equipment and recipe control. This allows the operator to make changes in batch recipes without any modifications to the equipment or additional engineering, thus saving the manufacturer time and money.

Connectivity
To avoid complications, manufacturers should choose independent software that supports a wide range of communication protocols. COPA-DATA’s zenon, for example, offers more than 300 high-performance interfaces that function in accordance with the ‘plug-and-play principle’. This makes it easy to implement and the user can start to collect, process and monitor production data straight away.

The communication model of the batch software extends upwards to fully integrate into manufacturing execution systems (MES) and business enterprise resource planning (ERP) systems. This links the raw material from goods-in through to the finished product at the customer’s site. The strong communication platform includes all layers of a production environment and extends to these systems.

Having no association with specific hardware providers ensures that regardless of the make and age of equipment, the batch software will be fully compatible and integrate seamlessly. Using this high level of connectivity minimises disruptions and quality problems, while also allowing pharmaceutical companies to collect data from the entire factory to archive digital records and ensure compliance across the processing line – allowing manufacturers to establish a fully connected smart factory.

Ergonomics
Lastly, understanding and using batch software should be stress free. As the pharmaceutical industry becomes more complex and more manufacturers begin exploring the realms of smart manufacturing, factory operators should be able to control and change batch production without complications.

By using software fitted with clear parameters and access levels, operators gain the ability to create and validate recipes, monitor the execution of production and review the performance of industrial machinery – without accidently altering or changing existing recipes and data. Reducing the amount of software engineering makes the operator’s life easier and minimises potential problems that could arise.

The benefits of complying with various industry regulations and standards do not stop with an enhanced Quality Management System (QMS). More customers will buy from you because you appear more reliable and your supply chain will see improved production indicators, such as increased OEE, reduced wastage, reduced recalls. On top of all of these benefits, you also improve product and thus patient safety.

To comply with industry standards, pharmaceutical companies should take steps to modernise their manufacturing processes, beginning with upgrading their batch control software. Anything else would be like putting the cart before the horse.

 

@copadata  @COPADATAUK #PAuto #SCADA

#EmrEX: All change at Brussell Centraal.

18/04/2016
Emerson User Group EMEA in Brussels, Belgium – 12th – 14th April 2016

“Seems to me that #EMrex is focusing not so much on new technologies, though important, but looking closer at how we do things.”  our tweet on day one.
Cfrpq9-UUAE8qVi

Brussels looked lovely on the morning that the Emerson User Group meeting opened. There was little to suggest the trauma that the city had faced just a few short weeks previously as delegates strolled through the sun-lit streets to the conference centre. The security however was markedly tighter as we entered the building however with strict adherence to the best security practices. However once inside the building things were as normal.

 Emerson Exchange Brussels – The Videos!

Other Reports (as they appear)
• Operational Excellence at Emerson Exchange Brussels (Emerson’s Stuart Turner – 20/4/2016).
• Nick Denbow ‘s travel travails: My worst week as an air traveller!  (30/4/2016)

Speaking with the organisers it promised to be a bumper event, stretched as it was over three days examining all aspects of automation, experiences, applications and of course exciting new products and concepts. The attendance was slightly down on the last time in Stuttgart, some were reluctant to travel, others were unable to make it due to the inability of the severely damaged to adhere to a normal service. Those who attended were in part in broad agreement with the message penned by Emerson’s Travis Hesketh – Standing up for Brussels. Indeed the User Group very quickly confirmed after these terrible events that they were going ahead with #EMrex. At several of the social events at the periphery, like the evening reception for publishers and journalists the people who suffered were remembered.

The venue was a modern conference and the one hundred or so presentations and industry forums were stretched over about six floors including an exhibition floor and at the very top of the building was a cyber café and a wonderful panoramic hall with the breathtaking view (featured at the top of this page from a tweet by Emerson’s social media guru – Jim Cahill)

But on to the the meeting!

Peter Iles-Smith of GlaxoSmithKline opened proceedings as chair of the Users Exchange Board. He welcomed the over two thousand delegates from so many countries through out the EMEA who travelled for the event.

Steve_SonnenbergSteve Sonnenberg, President Emerson Process Management (pictured right) and Roel VanDoren, their President in Europe, in a joint presentation entitled “New Reality, New Opportunity” addressed the changes and challenges facing companies in the 21st Century. They did not talk about products or applications but on ways of doing things. Indeed during the presentation we tweeted: “Emerson’s approach – yes equipment, but more importantly perhaps is attitude or culture.”

Nobody does business the way they it was done even twenty years ago, when the internet was a baby and nobody imagined never mind thought possible social media platforms like twitter,  yet in many cases industry is way behind in adapting to change. Possibilities are there which were inconceivable a short time ago and these need to be harnessed for the good of humanity.

Research into these possibilities, new technologies are leading to changes especially the importance of planning including all stakeholders at the earliest opportunity. This thinking is leading to an innovative technology and engineering-based approach for improved capital efficiency such as their Project Certainty approach  which aims to tackle complexity by decoupling the dependencies suppliers have on each other, eliminating bottlenecks and allowing concurrent work streams. In a word it aims to transform capital investment and releasing the frightening amounts of money currently being lost in big and not so big projects.

And these figures are frightening. If the type of approach spoken of here is adopted savings of up to €400 Billion (yes BILLION) would be released to invest in, for instance,  production, reliability, safety, energy, training, security and innovation.

So what is involved?

Xavier_MarchantXavier Marchant, (right), Emerson’s Vice President Process Systems and Solutions in Europe, gave dramatic examples of the possible savings in labour and materials. For instance the decision to use smart junction boxes in a large project could save both money and space (95% in control room space). Spare parts are another area where there is phenomenal waste. He quoted a spokesman from a International Energy and Chemical Company, “On our last construction project we overspent on maintenance spares to the tune of €50,000,000…we just wrote it off….because we did not have a robust spares analysis process.” Reduce the complexity by the involvement of stake holders at the start of planning for a project and allowing them to develop it side by side. One simple idea is to separate software from hardware in the development. The “old way” is to tie them together from the start whereas this way the software can be developed using virtual systems and then later on when the actual operation is seen to work in the virtual world (he called it virtual FAT – Factory Acceptance Test) it may be introduced to the real or concrete world – or “late binding” as he called it.

vFAT
Virtual FAT has far less chance of harming one than the real thing?

He quoted  François Davin of Sanofi “Emerson’s Remote Virtual Office allowed us to collaborate with experts and resources from multiple sites to conduct our Factory Acceptance Test (FAT). The result was less travel and site disturbance to our operations. Also, more operators could participate remotely which improved the new automation system adoption.”

We were introduced to the concept of  quartile performance and their site Top Quartile Performance is a exposé of how they view this as a concept and how it is influencing their thinking as a group.

Peter_Zornio

Of course all these changes would be impossible without the availability and enthusiastic embracing of the so-called “new” technologies. Peter Zornio (right), Emerson’s irrepressible Chief Strategic Officer, gave us an insight into these and how the company is using these and its co-operative involvement with the pioneers in these , the Internet of Everything(CISCO),  Industrial Internet (GE), Smart Planet (IBM) and The Internet of Things (Microsoft). These technologies, and others embryonic or not even conceived of are guiding  the current and future development of technology used in the manufacturing and processing sectors.

Keynotes: The Emerson User Exchanges whether in the USA or EMEA always have exciting and inspirational keynote speakers each day. This event was no exception. Jack Uldrich, a futurist spoke about future-proofing business. The majority of businesses are not ready for what is happening in the real world or for the speed at which it is happening.

Another of these speakers Prof Jan Rotmans who spoke about change. He maintains that we are not living through an “era of change” as a “change of era!” Many of us are in the old era, our mobile phone is just that, we read newspapers, buy books in bookshops. Our kids live on their mobile phones, they are their liveline. We are “old-fashioned” our kids are “cool!” Change is disruptive and the old ways are totally unable to cope. The old top-down certainties are dissolving and the “common man” is taking charge, sometimes violently. Chaos is the name of the game.

Finally a veteran at EmrEX, David Beckman, brought all the thoughts and ideas of New Reality, New Opportunity together. In view of Rotmans’ talk earlier the title he chose was more than relevant as he introduced delegates to the “Worst Case Scenario Survival Handbook.” Although he prepared us for worst case scenarios he described real opportunities for industrial automation.

Presentations. The various threads were divided into five headings or sectors, Business & Projects; Operate Safely, Securely and Legally; Process Optimisation; Maintenance & Reliabilitym and, Control System Applications & Migrations and were held through each of the days.

Forums: There were also Industry Forums with panels and general discussions on the various specialities e.g. Life Sciences or Refining & Petrochemicals. These were opportunities for participants to learn and exchange information and experiences with each other.

Training: There were also training  sessions and other sessions (called Roadmaps) on Emerson products and possible future developments.

projcertExpo

ExpoEmrEx16274Solutions EXPO: Of course no event is complete without actually seeing product and EmrEX is no exception. The floor was divided under the same zone headings as the threads of presentations above. (See sketch on left).

There were several unique exhibits. One was the Operations Centre of the Future. This was an imaginative presentation of a plant with a H.A.L. like computer responding (or not) to commands or requests from the operatives. It featured a drone delivery of spare parts and a really effective alarm situation which featured a realistic vibration of the floor. Of course the real message is that though it is the future most of the technology used is possible today.

Of course the Project Certainty concept featured prominently in the Business & Projects area and we were show possible scenarios. They had also rather bravely set up a wall where delegates could post what they consider are the features that should be addressed in projects. This should help “to focus ruthlessly on what’s directly relevent to a company strategy.”

Of course there were actual instruments on display to examine and handle.

Ind1stNotable was this industry first, the Rosemount X-well system, a wireless transmitter, accurately measuring process temperature without need for thermowell. Accurate process temperature measurement is possible without requiring any intrusions or penetrations into the process, allowing for quicker and easier installation along with simplified long-term maintenance. Users do not have to design, size or maintain thermowells. Wake Frequency Calculations are eliminated, as well as time spent determining material compatibility, the right insertion length and the necessary profile.

pressure_gaugeAlso the new Emerson Wireless Pressure Gauge created quite buzz among delgates. Th“This new gauge design fundamentally will change how customers use pressure gauges by helping them make better business decisions!”  It is another industry first. Does this signal the end of the Bourdon Tube?

Energy management is of course critical in all processes. It is effected not only by cost factors but also by legislation driven by concerns on pollution and global warming. Here Emerson demonstrated some prototypes of monitoring and control equipment not yet available. They emphasised savings on space occupied and of course ease of use by operatives.

Jim_CahillAnother very popular item was on the Maintenance & Reliability Zone. Here was an opportunity to experience the immersive training simulator. A goggle like apparatus was placed on the head and using a game-like hand piece the engineer is able to travel through a plant and see where various problems may be without any danger to him or her. It is a fascinating experience and one really feels that one is travelling through the plant rather than sitting or standing in a control room or office.  In this picture we see Emerson’s Chief Blogger, Surface Dweller, Head of Social Media enter the virtual world for real! We can confirm that he returned to real reality afterwards.

Around the periphery of the EXPO were the booths of companies which compliment the Emerson offering – what they call their complementary and strategic partners.

history-passageThere was also a section dedicated to history featuring milestones in science and automation over the years. It was a demonstration of change in the past. What will feature in future shows? The new opportunities taking advantage of the new realities of the past.

Always a major highlight of the Emerson User Group events is waht the call the “Networking Event.” This year was rather unique in that it was a visit to the Museum of Fine Arts and the Magritte Museum. This was an unique opportunity to see the best of Belgian painters – creativity of a different type than that extolled during the day sessions. Artists such as the Brueghels, Rubens, Jordaens and Magritte were enjoyed during this evening. Food and beverages were served – Belgium is famous for its beers of course but it also has its own cuisine and of course it’s chocolate is to die for.

This years event, despite the unexpected difficulties, was on a par, indeed because of these difficulties had perhaps more user participation than previous ones. There were many exciting things to see, concepts to understands and friends with which to share experiences.  And of course fun with a capital F.

Look at this and tell me people weren’t enjoying themselves! (Twitter pic ‏@Julian_Annison)

CgARbxJWQAAV7Vc

Emerson’s Travis Hesketh and Nick Taylor appreciating (?) art.


Our unedited photos from the conferenceon the Read-out Facebook page.

Follow on twitter #EmrEX

The videos here give an impression of each day:
Day One


Day Two


Day Three

• We have written about our travelling experiences to and from Brussels in our personnel blog (Sa Bhaile: (“Home” in Irish). These were relatively smooth if labourious but there is indeed no comparison to the experiences of Nick Denbow of ProcessingTalk which he outlines on their blog: My worst week as an air traveller! 


Previous EmrEX EMEA Events.
2014: Stuttgart: Revving up in Stuttgart!
2012: Duesseldorf: Automation returns to Düsseldorf!

All our reports on EmrEX Events (including North America).


#EMrex #PAuto @EmersonExchange @EmersonProcess #PAuto #IoT